Lixue Cao
Overview
Explore the profile of Lixue Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia B, Feng H, Jiang X, Guo J, Lin K, Zhang W, et al.
Pharmacol Res
. 2025 Jan;
213:107628.
PMID: 39880067
T-cell lymphomas (TCLs) are heterogeneous malignancies with limited treatment options and poor outcomes. The efficacy of traditional T-cell therapies, including chimeric antigen receptor (CAR) T cells, is often constrained by...
2.
Chen X, Li S, Cao L, Chen S, Lin Q, Zhong S
Discov Oncol
. 2025 Jan;
16(1):71.
PMID: 39836336
Liver hepatocellular carcinoma (LIHC) is a highly heterogeneous disease, necessitating the discovery of novel biomarkers to enhance individualized treatment approaches. Recent research has shown the significant involvement of ubiquitin-related genes...
3.
Li Z, Yang B, Long M, Chen J, Zhi Y, Li R, et al.
J Pathol
. 2025 Jan;
265(3):302-315.
PMID: 39804049
Aberrant expression of grainyhead-like transcription factor 3 (GRHL3) has been extensively reported in the development and progression of several squamous cell carcinomas, such as cutaneous, head and neck, and esophageal...
4.
Li L, Lei Q, Zhen Y, Cao L, Dong Y, Liu X, et al.
J Agric Food Chem
. 2024 Dec;
72(50):27953-27964.
PMID: 39632278
Hepatic stellate cells (HSCs) activation results in liver fibrosis. When HSCs are activated, metabolism is reprogrammed. However, metabolic alteration in HSCs activation has not been sufficiently addressed. This study aims...
5.
Cao L, Peng H, Chen Y, Xia B, Zeng T, Guo J, et al.
J Immunother Cancer
. 2024 Nov;
12(11).
PMID: 39532433
Background: The failure of conventional therapies and the propensity for recurrence and metastasis make triple-negative breast cancer (TNBC) a formidable challenge with grim prognoses and diminished survival rates. Immunotherapy, including...
6.
Chen J, Li Z, Zheng G, Cao L, Guo Y, Lian Q, et al.
NPJ Precis Oncol
. 2024 Nov;
8(1):258.
PMID: 39521913
This study investigates the role of RNF4-mediated ubiquitination and degradation of PDHA1 in colorectal cancer (CRC) metabolism and metastasis. Integrating (The Cancer Genome Atlas) TCGA and Clinical Proteomic Tumor Analysis...
7.
He Y, Zhang X, Zhang X, Fu B, Xing J, Fu R, et al.
Microbiol Spectr
. 2024 Jun;
12(8):e0031124.
PMID: 38916312
is a microaerophilic Gram-negative bacterium that resides in the human stomach and is classified as a class I carcinogen for gastric cancer. Numerous studies have demonstrated that infection plays a...
8.
Chen X, Peng H, Zhang Z, Yang C, Liu Y, Chen Y, et al.
Immunol Res
. 2024 Jun;
72(5):1030-1050.
PMID: 38890248
Breast cancer remains the most common malignant carcinoma among women globally and is resistant to several therapeutic agents. There is a need for novel targets to improve the prognosis of...
9.
Liu J, Xia B, Jiang X, Cao L, Xi Z, Liang L, et al.
Cancer Sci
. 2024 Jun;
115(8):2540-2552.
PMID: 38845192
The prognosis of patients with peripheral T-cell lymphoma (PTCL) depends on bone marrow involvement (BMI). The bone marrow (BM) tumor microenvironment in PTCL remains unclear. We performed single-cell RNA sequencing...
10.
Lv X, Chen R, Liang T, Peng H, Fang Q, Xiao S, et al.
mBio
. 2024 Feb;
15(3):e0335823.
PMID: 38303107
Importance: The outbreak of coronavirus disease 2019 (COVID-19) severely endangers global public health. The efficacy of vaccines and antibodies declined with the rapid emergence of severe acute respiratory syndrome coronavirus...